Defining mesenchymal stromal cell (MSC)‐derived small extracellular vesicles for therapeutic applications
Open Access
- 29 April 2019
- journal article
- research article
- Published by Wiley in Journal of Extracellular Vesicles
- Vol. 8 (1), 1609206
- https://doi.org/10.1080/20013078.2019.1609206
Abstract
Small extracellular vesicles (sEVs) from mesenchymal stromal/stem cells (MSCs) are transiting rapidly towards clinical applications. However, discrepancies and controversies about the biology, functions, and potency of MSC-sEVs have arisen due to several factors: the diversity of MSCs and their preparation; various methods of sEV production and separation; a lack of standardized quality assurance assays; and limited reproducibility of in vitro and in vivo functional assays. To address these issues, members of four societies (SOCRATES, ISEV, ISCT and ISBT) propose specific harmonization criteria for MSC-sEVs to facilitate data sharing and comparison, which should help to advance the field towards clinical applications. Specifically, MSC-sEVs should be defined by quantifiable metrics to identify the cellular origin of the sEVs in a preparation, presence of lipid-membrane vesicles, and the degree of physical and biochemical integrity of the vesicles. For practical purposes, new MSC-sEV preparations might also be measured against a well-characterized MSC-sEV biological reference. The ultimate goal of developing these metrics is to map aspects of MSC-sEV biology and therapeutic potency onto quantifiable features of each preparation.Keywords
This publication has 66 references indexed in Scilit:
- How pure are your vesicles?Journal of Extracellular Vesicles, 2013
- Therapeutic MSC exosomes are derived from lipid raft microdomains in the plasma membraneJournal of Extracellular Vesicles, 2013
- Extracellular vesicle sizing and enumeration by nanoparticle tracking analysisJournal of Extracellular Vesicles, 2013
- Safety of Cell Therapy with Mesenchymal Stromal Cells (SafeCell): A Systematic Review and Meta-Analysis of Clinical TrialsPLOS ONE, 2012
- Sizing and phenotyping of cellular vesicles using Nanoparticle Tracking AnalysisNanomedicine: Nanotechnology, Biology and Medicine, 2011
- Enabling a robust scalable manufacturing process for therapeutic exosomes through oncogenic immortalization of human ESC-derived MSCsJournal of Translational Medicine, 2011
- Human platelet lysate can replace fetal bovine serum for clinical‐scale expansion of functional mesenchymal stromal cellsTransfusion, 2007
- Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statementCytotherapy, 2006
- Platelet lysates promote mesenchymal stem cell expansion: A safety substitute for animal serum in cell-based therapy applicationsJournal of Cellular Physiology, 2005
- Receptor-mediated endocytosis of transferrin and recycling of the transferrin receptor in rat reticulocytes.The Journal of cell biology, 1983